SEC Form 4 · accession 0001232524-15-000169
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seamus Mulligan
Director
Period of report
Nov 20, 2015
Accepted (ET)
Nov 24, 2015 · 6:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Nov 20, 2015 | S | 12,325 | $144.1241 | D | 1,146,190 | D | |
| Ordinary SharesF3 | Nov 20, 2015 | S | 2,700 | $145.283 | D | 1,143,490 | D | |
| Ordinary SharesF4 | Nov 20, 2015 | S | 1,700 | $146.25 | D | 1,141,790 | D | |
| Ordinary SharesF5 | Nov 20, 2015 | S | 1,000 | $147.149 | D | 1,140,790 | D | |
| Ordinary SharesF6 | Nov 23, 2015 | S | 500 | $145.126 | D | 1,140,290 | D | |
| Ordinary SharesF7 | Nov 23, 2015 | S | 550 | $145.997 | D | 1,139,740 | D | |
| Ordinary SharesF8 | Nov 23, 2015 | S | 2,000 | $147.4964 | D | 1,137,740 | D | |
| Ordinary SharesF9 | Nov 23, 2015 | S | 5,628 | $148.0965 | D | 1,132,112 | D | |
| Ordinary SharesF10 | Nov 23, 2015 | S | 1,465 | $149.2062 | D | 1,130,647 | D | |
| Ordinary Shares | Nov 23, 2015 | S | 100 | $150.00 | D | 1,130,547 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F10Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.91 to $149.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F2Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $143.69 to $144.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.73 to $145.71. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.75 to $146.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $146.79 to $147.58. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F6Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.75 to $145.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F7Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.80 to $146.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F8Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $146.81 to $147.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F9Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.82 to $148.7325. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.